Federated scientific data only matters when it can decide

by Marina VasquezHead of Semantic Systems, HMND

Every platform demo in pharma still begins with a promise that the answers are already there, waiting to be extracted from one more layer, one more view, one more export job dressed up as progress. The older I get, the more I hear the same quiet confession underneath the demo: the team has data, but it has no agreed meaning, so every decision becomes a small customs inspection.

Discovery to release, with identity intact

A federated system earns its keep when a scientist in discovery, a translational analyst, a clinical operations lead, and a manufacturing reviewer can ask different questions over their own systems and still land on the same governed entities. Data federation is commonly described as a virtual, unified view over disparate sources without moving everything into one store, and recent work on federated research infrastructures keeps pushing the same point, with governance, policies, security, and sustainability treated as first class parts of the architecture. The useful part is not the virtual layer by itself. The useful part is the contract that says what a sample, an assay run, a batch, a subject, and a release record mean across domains.

That contract is what semantic data fabric people keep circling back to, even when the phrase gets used too loosely in vendor slide decks. In the more serious literature, federated ecosystems depend on standardized interfaces, semantic enrichment, transparent transactions, and decentralized governance with identity management at the edge. The architecture changes who can answer what, because the query no longer asks every team to reassemble the world before they speak. A portfolio lead can ask whether a biomarker signal survives from exploratory assay to clinical cohort without pretending the underlying ELN, LIMS, CTMS, and MES all share one native model. They do not. The semantic layer makes their differences legible.

The real bottleneck is meaning, then security

I keep thinking about the night shift in a manufacturing suite, because that is where the fiction of clean integration meets the actual sample. A batch fails release review, someone asks for provenance, and three systems answer with three versions of the same story, each technically true and operationally useless. If the identity of the batch, the assay, or the reference material changes across systems, the query result may be fast and still untrustworthy.

This is where HL7 FHIR matters as more than a healthcare acronym. FHIR gives a standard API and resource model for clinical exchange, which is why it keeps showing up in federation discussions around interoperable health and research data. In pharma, its value is less about ceremonial compliance and more about making clinical objects queryable in a controlled way across boundaries that were never designed for one another. A governed semantic model can sit above FHIR resources, assay ontologies, and manufacturing vocabularies and tell you which answers are allowed to be treated as equivalent, which require transformation, and which require human review. Confidence becomes a property of the model, not a mood in the dashboard.

FAIR without ownership is just a poster

FAIR principles still matter because they force the old infrastructure question back into the room: can someone else find, access, interoperate with, and reuse this data without filing a pilgrimage request through three committees. Federated infrastructures like DataFed were built around the same stubborn idea, using decentralized storage with central metadata and provenance management so data access stays simple and uniform across heterogeneous facilities. That combination is the part people underprice. Storage can remain distributed. Meaning cannot.

The adoption problem is not that teams hate interoperability. They hate the cost of becoming the next source system everyone blames when the ontology drifts. A governed semantic model changes the burden. Discovery no longer has to export everything to ask a portfolio question. Clinical does not need to flatten every nuance into a CSV before translational can use it. Manufacturing does not have to surrender its release logic just so analytics can pretend a batch is a row. The model decides which entity is canonical, which identifier survives movement, and which confidence level attaches to each answer. That is architecture with consequences, the sort that can stop a bad release decision before it gets dressed up as a data quality issue.

Marina would probably mutter, with some justice, that we spent years calling this integration when what we needed was agreement. She would be right. If two teams cannot agree what a sample is, the system is already failing upstream of any query engine.

If this kind of federated meaning problem is sitting in your stack, say hello at hello@example.com.